eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all . Please read our guidelines before submitting your own eLetter.
Research ArticleCORONAVIRUS
Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers
- View ORCID ProfileNoam Shental1,*,†,
- Shlomia Levy2,3,‡,
- Vered Wuvshet2,3,‡,
- Shosh Skorniakov2,3,‡,
- Bar Shalem4,
- View ORCID ProfileAner Ottolenghi2,3,
- Yariv Greenshpan2,3,
- Rachel Steinberg5,
- View ORCID ProfileAvishay Edri2,3,
- View ORCID ProfileRoni Gillis6,
- Michal Goldhirsh6,
- View ORCID ProfileKhen Moscovici6,
- View ORCID ProfileSinai Sachren3,
- View ORCID ProfileLilach M. Friedman2,3,
- View ORCID ProfileLior Nesher5,
- Yonat Shemer-Avni2,5,
- View ORCID ProfileAngel Porgador2,3,*,† and
- View ORCID ProfileTomer Hertz2,3,7,*
- 1Department of Computer Science, The Open University of Israel, Ra’anana, Israel.
- 2Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- 3National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- 4Department of Computer Science, Bar-Ilan University, Ramat Gan, Israel.
- 5Soroka University Medical Center, Beer-Sheva, Israel.
- 6Goldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- 7Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
- ↵†Corresponding author. Email: angel{at}bgu.ac.il (A.P.); shental{at}openu.ac.il (N.S.); thertz{at}bgu.ac.il (T.H.)
See allHide authors and affiliations
Science Advances 11 Sep 2020:
Vol. 6, no. 37, eabc5961
DOI: 10.1126/sciadv.abc5961
Vol. 6, no. 37, eabc5961
DOI: 10.1126/sciadv.abc5961
Noam Shental
1Department of Computer Science, The Open University of Israel, Ra’anana, Israel.
Shlomia Levy
2Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
3National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Vered Wuvshet
2Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
3National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Shosh Skorniakov
2Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
3National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Bar Shalem
4Department of Computer Science, Bar-Ilan University, Ramat Gan, Israel.
Aner Ottolenghi
2Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
3National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Yariv Greenshpan
2Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
3National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Rachel Steinberg
5Soroka University Medical Center, Beer-Sheva, Israel.
Avishay Edri
2Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
3National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Roni Gillis
6Goldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Michal Goldhirsh
6Goldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Khen Moscovici
6Goldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Sinai Sachren
3National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Lilach M. Friedman
2Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
3National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Lior Nesher
5Soroka University Medical Center, Beer-Sheva, Israel.
Yonat Shemer-Avni
2Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
5Soroka University Medical Center, Beer-Sheva, Israel.
Angel Porgador
2Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
3National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Tomer Hertz
2Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
3National Institute of Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
7Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Submit a Response to This Article
No eLetters have been published for this article.